標題: Titlebook: Biologics to Treat Substance Use Disorders; Vaccines, Monoclonal Ivan D. Montoya Book 2016 Springer International Publishing Switzerland 20 [打印本頁] 作者: 拼圖游戲 時間: 2025-3-21 18:40
書目名稱Biologics to Treat Substance Use Disorders影響因子(影響力)
書目名稱Biologics to Treat Substance Use Disorders影響因子(影響力)學科排名
書目名稱Biologics to Treat Substance Use Disorders網(wǎng)絡(luò)公開度
書目名稱Biologics to Treat Substance Use Disorders網(wǎng)絡(luò)公開度學科排名
書目名稱Biologics to Treat Substance Use Disorders被引頻次
書目名稱Biologics to Treat Substance Use Disorders被引頻次學科排名
書目名稱Biologics to Treat Substance Use Disorders年度引用
書目名稱Biologics to Treat Substance Use Disorders年度引用學科排名
書目名稱Biologics to Treat Substance Use Disorders讀者反饋
書目名稱Biologics to Treat Substance Use Disorders讀者反饋學科排名
作者: obstinate 時間: 2025-3-21 22:36 作者: Panacea 時間: 2025-3-22 03:32 作者: 染色體 時間: 2025-3-22 08:30 作者: 包庇 時間: 2025-3-22 11:07 作者: Allege 時間: 2025-3-22 16:58 作者: 條約 時間: 2025-3-22 19:13
Book 2016uspsychiatric conditions. . .Writtenby experts in the field, .Biologics to Treat Substance Use Disorders .is asan authoritative reference for psychiatrists, psychologists, and all othermedical professionals working with patients suffering from Substance UseDisorders..作者: Frequency 時間: 2025-3-22 23:01 作者: Painstaking 時間: 2025-3-23 03:10
Book 2016forthe treatment of Substance Use Disorders (SUDs). The book gives detailedconsideration to some of the most cutting edge topics in addiction medicine,including vaccines for nicotine, cocaine, heroin, and methamphetaminedependence; monoclonal antibodies against cocaine, methamphetamine, andphencycli作者: Hiatus 時間: 2025-3-23 06:52
https://doi.org/10.1007/978-3-540-71408-8ccine in animals, it will be beneficial to focus research efforts on those vaccines that are made from components that can be administered to humans. Although further research is needed, results support the potential utility of developing anti-MA vaccines for the treatment of MA abuse in humans.作者: 鍍金 時間: 2025-3-23 12:19 作者: 吞沒 時間: 2025-3-23 15:56 作者: extemporaneous 時間: 2025-3-23 20:30
Summary and Critical Reflectionn and Li 2012; Winchell et al. 2012; Donovan et al. 2012), low medication compliance during the conduct of clinical trials (Anderson et al. 2012, 2014; Somoza et al. 2013), and, with few exceptions, the perception by pharma that developing medications to treat SUDs will not provide a favorable retur作者: aristocracy 時間: 2025-3-24 00:13 作者: antenna 時間: 2025-3-24 03:22
Summary and Critical Reflectionbodies as catalysts for the metabolism of cocaine, researchers produced antibodies against the cocaine itself in human subjects..This cocaine vaccine now has been through late phase II clinical trials. The mechanism of action for this vaccine is to induce antibodies to the cocaine, which act kinetic作者: CRP743 時間: 2025-3-24 08:38 作者: Preamble 時間: 2025-3-24 14:10 作者: 外星人 時間: 2025-3-24 17:33 作者: concubine 時間: 2025-3-24 22:21
Procedure, Methods and Overview make this enzyme useful for most cocaine abusers. Pharmacological and behavioral procedures for evaluation of compounds of interest exist at both the preclinical and clinical levels. Discovery technology is making great strides toward the development of long-lasting enzyme therapeutics.作者: 濕潤 時間: 2025-3-24 23:29
Summary and Critical Reflection vaccine platform using cocaine and nicotine targets. Summaries are provided of the supporting data for efficacy in mice, rats, and non-human primates with phenotypes that include drug biodistribution, drug-induced locomotor behavior, drug self-administration, and positron emission tomography of dru作者: 輕快走過 時間: 2025-3-25 03:52
https://doi.org/10.1007/978-3-540-71408-8d Manufacturing Practices (GMP). This chapter describes the self-assembling nanoparticle-based vaccines or synthetic vaccine particle (SVP) technology to induce antibodies against nicotine and potentially treat nicotine dependence.作者: 錯誤 時間: 2025-3-25 08:02
Cocaine Hydrolases Designed from Butyrylcholinesterase作者: 縱火 時間: 2025-3-25 12:31
Introduction: Biologics to Treat Substance Use Disorders: Vaccines, Monoclonal Antibodies, and Enzyn and Li 2012; Winchell et al. 2012; Donovan et al. 2012), low medication compliance during the conduct of clinical trials (Anderson et al. 2012, 2014; Somoza et al. 2013), and, with few exceptions, the perception by pharma that developing medications to treat SUDs will not provide a favorable retur作者: GEAR 時間: 2025-3-25 16:11
Therapeutic Vaccines for Treating Nicotine Addictionr the pharmacokinetics (PK) of nicotine, slowing and reducing its entry into the brain and attenuating its reinforcing effects by binding nicotine in the blood (Gorelick, Future Med Chem 4(2):227–243, 2012). Extensive preclinical and clinical research has been conducted on nicotine conjugate vaccine作者: Prologue 時間: 2025-3-25 22:16
Vaccines for Treating Cocaine Use Disordersbodies as catalysts for the metabolism of cocaine, researchers produced antibodies against the cocaine itself in human subjects..This cocaine vaccine now has been through late phase II clinical trials. The mechanism of action for this vaccine is to induce antibodies to the cocaine, which act kinetic作者: acetylcholine 時間: 2025-3-26 03:38
Vaccines for Opioid Addictionr slowing their distribution to the brain, and attenuating addiction-relevant behaviors including heroin self-administration and reinstatement. The antibodies elicited by vaccines directed at heroin and its metabolites do not appreciably cross-react with methadone, buprenorphine, or naltrexone and s作者: SCORE 時間: 2025-3-26 04:26
Cocaine and HIV Infection al. 2009), highlighting the extreme complexity of the overlapping epidemiologic landscape of cocaine use and HIV infection in the United States. The recent availability of the first prototypes of HIV and cocaine vaccines raises the question of the impact of these biological/medicinal interventions 作者: 流逝 時間: 2025-3-26 09:59 作者: 一大群 時間: 2025-3-26 13:08
Enzyme-Based Cocaine Pharmacotherapies: Current Status and Projections for the Future make this enzyme useful for most cocaine abusers. Pharmacological and behavioral procedures for evaluation of compounds of interest exist at both the preclinical and clinical levels. Discovery technology is making great strides toward the development of long-lasting enzyme therapeutics.作者: Hippocampus 時間: 2025-3-26 19:13
Adenovirus-Based Vaccines for the Treatment of Substance Use Disorders vaccine platform using cocaine and nicotine targets. Summaries are provided of the supporting data for efficacy in mice, rats, and non-human primates with phenotypes that include drug biodistribution, drug-induced locomotor behavior, drug self-administration, and positron emission tomography of dru作者: 躺下殘殺 時間: 2025-3-26 21:35 作者: packet 時間: 2025-3-27 04:05 作者: 反饋 時間: 2025-3-27 06:44
Therapeutic Vaccines for Treating Nicotine Addictionof progress. A report of the Surgeon General, 2014). The Centers for Disease Control estimates that the direct healthcare costs attributable to treating smoking and smoking-attributable illness exceed $170 billion per year (CDC, Smoking & Tobacco Use: Fast Facts, 2015). Only one in five smokers achi作者: Silent-Ischemia 時間: 2025-3-27 10:22 作者: 左右連貫 時間: 2025-3-27 15:32 作者: OPINE 時間: 2025-3-27 19:15 作者: 討好美人 時間: 2025-3-27 23:22
Cocaine and HIV Infection in the United States, and PWID are incontrovertibly at risk for HIV acquisition (Friedman et al. 1989). In addition, there are many other complex direct and indirect associations in different populations between cocaine use and HIV infection. Cocaine use is associated in various contexts with a gre作者: minaret 時間: 2025-3-28 05:01 作者: N防腐劑 時間: 2025-3-28 06:26
Anti-cocaine Monoclonal Antibodiess have many advantages as an immunotherapy for cocaine abuse, the use of anti-cocaine mAbs addresses the limitations of cocaine vaccines: the polyclonal response that produces between-patient variability of affinities of the antibodies raised, the amount of antibodies raised, and the delay in the pr作者: CLIFF 時間: 2025-3-28 12:59
Discovery and Development of an Anti-methamphetamine Monoclonal Antibody for Use in Treating Methamper than a direct action in the brain, the mAb medication binds METH with high affinity in the bloodstream leading to a reduction and slowing of METH brain penetration. Through an extensive discovery and development process, prototype mouse anti-METH mAb medications were selected and tested in precli作者: Cerumen 時間: 2025-3-28 16:05 作者: indifferent 時間: 2025-3-28 22:45
Viral Gene Transfer of Enzymesa highly efficient cocaine hydrolase that reduces or prevents cocaine access to reward centers in the brain. A theoretical rationale for this approach will be presented first, followed by a brief survey of viral gene transfer in terms of risks and benefits from specific classes of agents that might 作者: 泄露 時間: 2025-3-29 00:10
Adenovirus-Based Vaccines for the Treatment of Substance Use Disordersantibodies can bind to addictive drugs in the blood preventing them from crossing the blood–brain barrier, the development of anti-addictive drug vaccines can prevent the administered drugs from reaching their cognate receptors in the brain. Vaccine strategies against addictive drugs have included l作者: 健談的人 時間: 2025-3-29 03:39 作者: 領(lǐng)導(dǎo)權(quán) 時間: 2025-3-29 10:15
Exploration of DNA Nanostructures for Rational Design of Vaccinesyet been fully realized in part due to insufficient immunogenicity of the small chemical compounds displayed on the vaccines. Over the past decade, extensive research effort, includi from modification of hapten linker structures and carrier proteins, addition of various adjuvants, and exploration of作者: headway 時間: 2025-3-29 14:38
Ivan D. MontoyaCovers all aspects of vaccines and other biologics employed for treatment of substance use disorders.Discusses novel strategies to optimize the development and efficacy of biologics.Written and edited作者: Atheroma 時間: 2025-3-29 18:37
http://image.papertrans.cn/b/image/187536.jpg作者: Banquet 時間: 2025-3-29 22:37 作者: NOVA 時間: 2025-3-30 01:18
978-3-319-79451-8Springer International Publishing Switzerland 2016作者: 遍及 時間: 2025-3-30 05:04
Monoclonal Antibodiesn 1975. To make this discovery, they developed a lymphocyte fusion technique that allowed selection of monoclonal antibodies of refined specificity and affinity. They received a Noble Prize in Physiology or Medicine in 1984 for this breakthrough innovation.作者: 積極詞匯 時間: 2025-3-30 08:57
Summary and Critical Reflection example, there are no FDA-approved medications to treat stimulant (e.g., cocaine and methamphetamine) use disorders, and based on an analysis of trials listed on www.clinicaltrials.gov, no approvals are anticipated during the next 5–7 years. Even when multiple pharmacotherapies are available (e.g.,作者: 放大 時間: 2025-3-30 14:20
Procedure, Methods and Overviewof progress. A report of the Surgeon General, 2014). The Centers for Disease Control estimates that the direct healthcare costs attributable to treating smoking and smoking-attributable illness exceed $170 billion per year (CDC, Smoking & Tobacco Use: Fast Facts, 2015). Only one in five smokers achi作者: Tonometry 時間: 2025-3-30 17:31 作者: 步兵 時間: 2025-3-30 22:16 作者: OCTO 時間: 2025-3-31 04:01
